News Home

Should Biotechnology Stock Brainstorm Cell Therapeutics Inc (BCLI) Be in Your Portfolio Thursday?

Thursday, August 18, 2022 12:04 PM | InvestorsObserver Analysts
Should Biotechnology Stock Brainstorm Cell Therapeutics Inc (BCLI) Be in Your Portfolio Thursday?

Brainstorm Cell Therapeutics Inc (BCLI) is around the top of the Biotechnology industry according to InvestorsObserver. BCLI received an overall rating of 86, which means that it scores higher than 86 percent of all stocks. Brainstorm Cell Therapeutics Inc also achieved a score of 97 in the Biotechnology industry, putting it above 97 percent of Biotechnology stocks. Biotechnology is ranked 29 out of the 148 industries.

Overall Score - 86
BCLI has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on BCLI!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Brainstorm Cell Therapeutics Inc Stock Today?

Brainstorm Cell Therapeutics Inc (BCLI) stock is trading at $3.91 as of 12:00 PM on Thursday, Aug 18, an increase of $0.06, or 1.56% from the previous closing price of $3.85. The stock has traded between $3.86 and $4.10 so far today. Volume today is 145,384 compared to average volume of 149,356. Click Here to get the full Stock Report for Brainstorm Cell Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App